LATISSE® 5 mL
Larger supply for ongoing treatment with sterile applicators included.
LATISSE® (bimatoprost ophthalmic solution) 0.03% is a prescription treatment for inadequate eyelashes that increases lash growth, including length, thickness, and darkness.
LATISSE® is FDA approved for eyelash hypotrichosis and works progressively with consistent use. Clinical information from the manufacturer reports visible improvement beginning during treatment, with full results evaluated at 16 weeks.
If treatment is discontinued, lashes are expected to gradually return toward their pretreatment appearance.
Select an option to open the Vydration product page and continue with the online visit and purchase process.
Larger supply for ongoing treatment with sterile applicators included.
Smaller supply option for eligible patients beginning or continuing treatment.
LATISSE® is generally applied once daily at night to the skin along the upper eyelid margin using a sterile applicator, as directed by the prescribing clinician.
Lash improvement develops gradually. Manufacturer clinical data evaluated fuller, longer, and darker eyelashes over a 16-week treatment period.
A licensed clinician must determine whether LATISSE® is appropriate based on your health history, eye history, medications, and other relevant factors.
Do not use LATISSE® if you are allergic to bimatoprost or any ingredient in the product. Patients using medications for elevated eye pressure or with certain eye conditions should discuss LATISSE® with their clinician or eye-care professional before use.
Possible effects include eye itching or redness, skin darkening around the application area, irritation, dry-eye symptoms, and eyelid redness. Increased brown iris pigmentation has also been reported with bimatoprost and may be permanent.
Apply only as prescribed to the upper eyelid margin. Avoid repeated contact with other skin areas because unwanted hair growth may occur. This page is not a substitute for the full prescribing information or advice from your clinician.